文献速递冠心病血脂与心血管预防

非ST段抬高型急性冠脉综合征患者冠状动脉造影前的出血事件

Bleeding Events Before Coronary Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.
PubMed 文献 · J Am Coll Cardiol · 2016-01-01

基于ACUITY试验中13,726例计划行冠状动脉造影的非ST段抬高型急性冠脉综合征患者,造影前275例(2.0%)发生出血,其中52例(0.4%)为大出血。出血与年龄、肾功能不全及多种抗血栓药物使用独立相关,并与住院时间延长及1年死亡风险升高相关(8.5% vs 4.1%;校正HR 1.89)。作者认为造影前上游抗血栓治疗与出血及死亡风险相关,避免出血策略包括早期造影可能改善风险获益平衡。

要点

  • 造影前出血发生率2.0%,大出血0.4%,出血事件随时间线性累积,96小时达10.4%。
  • 出血独立预测因素包括年龄(每岁校正HR 1.03)、肾功能不全(校正HR 1.48)和多种抗血栓药物使用(校正HR 1.33)。
  • 造影前出血者1年死亡率8.5% vs 未出血者4.1%(校正HR 1.89,95%CI 1.23-2.90)。

核心结论

  • 非ST段抬高型急性冠脉综合征患者等待冠状动脉造影期间上游抗血栓治疗与出血增加相关,并具有死亡风险含义。
  • 作者认为造影前避免出血策略包括早期造影,可能消除延长上游抗血栓治疗的需要并改善整体风险获益平衡。

研究设计与样本

  • ACUITY(急性导管插入和紧急干预分诊策略)试验中所有入组后计划行冠状动脉造影的患者被纳入分析。
  • 出血事件按ACUITY量表分为大出血或非大出血,采用Kaplan-Meier和Cox比例风险分析。

主要发现

  • 13,726例患者中,275例(2.0%)在造影前出血,包括52例(0.4%)大出血;44例(0.3%)发生心肌梗死。
  • 未出血患者从随机化至冠状动脉造影的中位时间为4.5小时(IQR 1.7至19.7小时),出血患者为27.9小时(IQR 21.9至65.6小时)(p < 0.001)。
  • 出血事件随时间线性累积,随机化后96小时达10.4%。
  • 造影前出血与住院时间延长相关(4.8天[IQR 3.0至8.9天] vs 3.0天[IQR 1.9至5.9天];p < 0.001)。
  • 造影前出血患者1年内死亡可能性高于未出血患者(8.5% vs 4.1%;p < 0.001;校正HR 1.89,95%CI 1.23至2.90;p = 0.004)。

关键数值与推荐

  • 年龄为造影前出血的独立预测因素(每岁校正HR 1.03;95%CI 1.01至1.04;p < 0.001)。
  • 肾功能不全是造影前出血的独立预测因素(校正HR 1.48;95%CI 1.07至2.04;p = 0.02)。
  • 使用多种抗血栓药物是造影前出血的独立预测因素(校正HR 1.33;95%CI 1.14至1.56;p < 0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Upstream administration of antithrombotic drugs to patients with non-ST-segment elevation acute coronary syndromes before coronary angiography is a common practice despite an incomplete understanding of the risks and benefits. OBJECTIVES: The authors analyzed the incidence of bleeding and ischemic events occurring before angiography and assessed their association with antithrombotic drugs and mortality risk. METHODS: All patients from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial with planned angiography after enrollment were included. Bleeding events were classified according to the ACUITY scale as major or nonmajor bleeding. Kaplan-Meier and Cox proportional hazards analyses were performed. RESULTS: Of 13,726 patients, 275 (2.0%) bled before angiography, including 52 (0.4%) with major bleeding. Forty-four (0.3%) experienced myocardial infarction. The median time from randomization to coronary angiography was 4.5 h (interquartile ratio [IQR]: 1.7 to 19.7 h) for patients who did not bleed while waiting for angiography and 27.9 h (IQR: 21.9 to 65.6 h) for patients who bled while waiting for angiography (p < 0.001). Bleeding events accrued linearly over time, reaching 10.4% at 96 h post-randomization. Independent predictors of bleeding before angiography included age (adjusted hazard ratio [HR]: 1.03 per year of age; 95% confidence interval [CI]: 1.01 to 1.04; p < 0.001), renal insufficiency (adjusted HR: 1.48; 95% CI: 1.07 to 2.04; p = 0.02), and use of multiple antithrombotic drugs (adjusted HR: 1.33; 95% CI: 1.14 to 1.56; p < 0.001). Bleeding before coronary angiography was associated with longer hospitalization (4.8 days [IQR: 3.0 to 8.9 days] vs. 3.0 days [IQR: 1.9 to 5.9 days]; p < 0.001). Patients who bled before angiography were more likely to die within 1 year than patients who did not bleed (8.5% vs. 4.1%; p < 0.001; adjusted HR: 1.89 (95% CI: 1.23 to 2.90; p = 0.004). CONCLUSIONS: Upstream antithrombotic treatment of patients with non-ST-segment elevation acute coronary syndromes awaiting coronary angiography is associated with excess bleeding with mortality implications. Bleeding avoidance strategies before angiogram, including early angiography, may negate the need to prolong upstream antithrombotic treatment and improve the overall risk-benefit balance for these patients. (Acute Catheterization and Urgent Intervention Triage Strategy [ACUITY]; NCT00093158).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Redfors B, Kirtane AJ, Pocock SJ, et al. Bleeding Events Before Coronary Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome. J Am Coll Cardiol. 2016. PMID: 27978944. doi:10.1016/j.jacc.2016.09.957

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。